Phase 2, Phase 3 Recruiting Network
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protoco…
Sponsor: SWOG Cancer Research Network
NCT ID: NCT03851445
Sites in Montana: - Community Hospital of Anaconda — Anaconda, Montana
- Billings Clinic Cancer Center — Billings, Montana
- Bozeman Health Deaconess Hospital — Bozeman, Montana
- Saint James Community Hospital and Cancer Treatment Center — Butte, Montana
- Benefis Sletten Cancer Institute — Great Falls, Montana
Phase 3 Recruiting NIH
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a…
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT04181060
Sites in Montana: - Community Hospital of Anaconda — Anaconda, Montana
- Billings Clinic Cancer Center — Billings, Montana
- Bozeman Health Deaconess Hospital — Bozeman, Montana
- Benefis Sletten Cancer Institute — Great Falls, Montana
- Great Falls Clinic — Great Falls, Montana
Phase 3 Recruiting Industry
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cance…
Sponsor: Pfizer
NCT ID: NCT07144280
Sites in Montana: - Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana — Billings, Montana
Phase 3 Recruiting Industry
The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (with nodal involvement \[N2\]) non-smal…
Sponsor: Merck Sharp & Dohme LLC
NCT ID: NCT06077760
Sites in Montana: - St. Vincent Frontier Cancer Center ( Site 0043) — Billings, Montana
Phase 3 Recruiting Industry
The purpose of this study is to evaluate efficacy and safety of Dato-DXd in combination with rilvegostomig or rilvegostomig monotherapy compared with pembrolizumab monotherapy as a first line therapy in participants with locally advanced o…
Sponsor: AstraZeneca
NCT ID: NCT06357533
Sites in Montana: - Research Site — Bozeman, Montana
Phase 3 Recruiting Industry
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.
Sponsor: Revolution Medicines, Inc.
NCT ID: NCT06881784
Sites in Montana: - St. Vincent Frontier Cancer Center — Billings, Montana
Phase 3 Recruiting Industry
This clinical trial is designed to assess the efficacy and safety of trastuzumab deruxtecan (T-DXd; Enhertu®) in combination with pembrolizumab versus platinum-based chemotherapy in combination with pembrolizumab in participants with no pr…
Sponsor: Daiichi Sankyo
NCT ID: NCT06899126
Sites in Montana: - Logan Health Research — Kalispell, Montana
Phase 2 Recruiting Network
This phase II trial tests how well biomarker tests on patients tumor tissue works in selecting personalized treatments for patients with extensive stage small cell lung cancer (ES-SCLC). Biomarker tests look for certain features in cancer …
Sponsor: SWOG Cancer Research Network
NCT ID: NCT06769126
Sites in Montana: - Community Hospital of Anaconda — Anaconda, Montana
- Billings Clinic Cancer Center — Billings, Montana
- Bozeman Health Deaconess Hospital — Bozeman, Montana
- Benefis Sletten Cancer Institute — Great Falls, Montana
- Community Medical Center — Missoula, Montana
Phase 1, Phase 2 Recruiting Industry
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors as a monotherapy or combined with Standard(s) of Care (SOC) or with each othe…
Sponsor: Revolution Medicines, Inc.
NCT ID: NCT06162221
Sites in Montana: - Intermountain Health - St. Vincent Frontier Cancer Center — Billings, Montana
Recruiting Academic/Other
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…
Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in Montana: - Community Hospital of Anaconda — Anaconda, Montana
- Billings Clinic Cancer Center — Billings, Montana
- Bozeman Health Deaconess Hospital — Bozeman, Montana
- Benefis Sletten Cancer Institute — Great Falls, Montana
- Great Falls Clinic — Great Falls, Montana
Recruiting Academic/Other
This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …
Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in Montana: - Community Hospital of Anaconda — Anaconda, Montana
- Billings Clinic Cancer Center — Billings, Montana
- Montana Cancer Consortium NCORP — Billings, Montana
- Bozeman Health Deaconess Hospital — Bozeman, Montana
- Benefis Sletten Cancer Institute — Great Falls, Montana
Recruiting Industry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…
Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in Montana: - Massive Bio SYNERGY-AI site — Billings, Montana
Recruiting Academic/Other
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess s…
Sponsor: Addario Lung Cancer Medical Institute
NCT ID: NCT06486428
Sites in Montana: - Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html — Multiple Locations, Montana